PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAxsome Therapeutics
Axsome Therapeutics(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AuvelityDextromethorphan, Bupropion2022-08-182023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Toothache
,
Dysmenorrhea
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine disorders
,
headache
,
epilepsy
,
recurrence
Dextromethorphan
respiratory tract infections
,
common cold
Bupropion
healthy volunteers/patients
,
depression
,
depressive disorder
,
tobacco use disorder
,
overweight
,
body weight
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
cardiovascular diseases
Meloxicam
healthy volunteers/patients
Bupropion hydrochloride
therapeutic equivalency
Glutamic acid
lung neoplasms
,
neoplasm metastasis
,
neoplasms
,
head and neck neoplasms
,
recurrence
,
carcinoma
,
small cell lung carcinoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
,
non-small-cell lung carcinoma
Doconexent
chronic renal insufficiency
,
pituitary diseases
,
turner syndrome
,
failure to thrive
,
dwarfism
Esreboxetine
hyperalgesia
,
fibromyalgia
Reboxetine
sleepiness
,
narcolepsy
,
cataplexy
,
disorders of excessive somnolence
D-glutamate
non-small-cell lung carcinoma
,
healthy volunteers/patients
,
schizophrenia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
Buproprion
healthy volunteers/patients
,
bipolar disorder
,
binge drinking
,
second primary neoplasms
,
addictive behavior
,
alcoholism
,
non-small-cell lung carcinoma
,
lung neoplasms
,
mood disorders
,
hiv infections
,
substance-related disorders
,
smoking cessation
,
smoking
,
treatment-resistant depressive disorder
,
alzheimer disease
,
dementia
,
crohn disease
,
huntington disease
,
chorea
,
depressive disorder
,
major depressive disorder
,
depression
,
tobacco use disorder
Nicoderm
schizophrenia
,
psychotic disorders
,
tobacco use disorder
,
smoking cessation
,
mental disorders
,
problem behavior
,
tobacco use cessation
,
smoking
,
substance withdrawal syndrome
,
alcoholic intoxication
,
alcohol drinking
,
cigarette smoking
,
ulcerative colitis
,
crohn disease
,
colitis
,
ulcer
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use